Kronos Bio Statistics Share Statistics Kronos Bio has 60.97M
shares outstanding. The number of shares has increased by 1.12%
in one year.
Shares Outstanding 60.97M Shares Change (YoY) 1.12% Shares Change (QoQ) 0% Owned by Institutions (%) 31.46% Shares Floating 58.9M Failed to Deliver (FTD) Shares 53,886 FTD / Avg. Volume 6.3%
Short Selling Information The latest short interest is 877.48K, so 1.44% of the outstanding
shares have been sold short.
Short Interest 877.48K Short % of Shares Out 1.44% Short % of Float 1.93% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.66 and the forward
PE ratio is -0.65.
Kronos Bio's PEG ratio is
0.02.
PE Ratio -0.66 Forward PE -0.65 PS Ratio 5.79 Forward PS 4.2 PB Ratio 0.65 P/FCF Ratio -0.87 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kronos Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.54,
with a Debt / Equity ratio of 0.28.
Current Ratio 7.54 Quick Ratio 7.54 Debt / Equity 0.28 Debt / EBITDA -0.4 Debt / FCF -0.38 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.23M Profits Per Employee $-10.76M Employee Count 8 Asset Turnover 0.08 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -14.56% in the
last 52 weeks. The beta is 1.64, so Kronos Bio's
price volatility has been higher than the market average.
Beta 1.64 52-Week Price Change -14.56% 50-Day Moving Average 0.8 200-Day Moving Average 0.9 Relative Strength Index (RSI) 65.76 Average Volume (20 Days) 855,959
Income Statement In the last 12 months, Kronos Bio had revenue of 9.85M
and earned -86.08M
in profits. Earnings per share was -1.43.
Revenue 9.85M Gross Profit 9.85M Operating Income -92.89M Net Income -86.08M EBITDA -61.72M EBIT -63.43M Earnings Per Share (EPS) -1.43
Full Income Statement Balance Sheet The company has 84.57M in cash and 24.9M in
debt, giving a net cash position of 59.67M.
Cash & Cash Equivalents 84.57M Total Debt 24.9M Net Cash 59.67M Retained Earnings -594.94M Total Assets 108.14M Working Capital 93.99M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -65.44M
and capital expenditures -4K, giving a free cash flow of -65.44M.
Operating Cash Flow -65.44M Capital Expenditures -4K Free Cash Flow -65.44M FCF Per Share -1.09
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -943.21% and -874.08%.
Gross Margin 100% Operating Margin -943.21% Pretax Margin -874.08% Profit Margin -874.08% EBITDA Margin -626.69% EBIT Margin -943.21% FCF Margin -664.49%
